| Literature DB >> 30989144 |
Michał Stosik1, Beata Tokarz-Deptuła2, Wiesław Deptuła3.
Abstract
Thrombocytes in vertebrates other than mammals, inter alia in fish, are analogues of platelets in mammals. In Osteichthyes, these cells take part in haemostatic processes, including aggregation and release reactions in cases of blood vessel damage, and in the immune response development as well. This paper discusses the development of thrombocytes in Osteichthyes, taking into account the need to make changes to the concept of grouping progenitor cells as suggested in the literature. The following pages present the morphological and cytochemical properties of thrombocytes as well as their defence functions, and also point out differences between thrombocytes in fish and platelets in mammals. The paper further highlights the level of thrombocytes' immune activity observed in fish and based on an increased proportion of these cells in response to antigenic stimulation, on morphological shifts towards forms characteristic of dendritic cells after antigenic stimulation and on the presence of surface structures and cytokines released through, inter alia, gene expression of TLR receptors, MHC class II protein-coding genes and pro-inflammatory cytokines. The study also points out the need to recognise thrombocytes in Osteichthyes as specialised immune cells conditioning non-specific immune mechanisms and playing an important role in affecting adaptive immune mechanisms.Entities:
Keywords: cytochemistry; defence functions; development; morphology; thrombocytes in fish
Year: 2019 PMID: 30989144 PMCID: PMC6458560 DOI: 10.2478/jvetres-2019-0017
Source DB: PubMed Journal: J Vet Res ISSN: 2450-7393 Impact factor: 1.744
Fig. 1The classical haematopoiesis model and another one, based on myeloid cells, as proposed by Kawamoto and Katsura (16). HSCs – haematopoietic stem cells, LT-HSCs – long term HSCs, HSC populations ability to self-renew, ST-HPCs – short term haematopoietic progenitor cells HPCs, limited ability to self-renew, MPPs – multi-potent progenitors, no ability to self-renew,
a/ CMP – common myeloid progenitor, LMPPs – lymphoid-myeloid primed multi-potent progenitor, MEP – megakaryocyte/erythrocyte progenitor, in mammals, TEP – thrombocytic/erythrocyte progenitor, in vertebrates other than mammals, GMP – granulocyte/macrophage progenitor, CLP – common lymphoid precursor, THR – thrombocytes in fish, MEG – megakaryocytes in mammals, ERTH – erythrocytes in mammals and fish,
b/ M – prototype of blood cells (prototype myeloid cell lineage/prototype of haematopoietic cells which covering cells that phagocytise monocytes/macrophages, granulocytes and thrombocytes, featuring basic defence mechanisms, such as phagocytic activity and mobility), E – cells representing a specialised erythroid cell lineage, T – cells representing a specialised T-cell lineage, B – cells representing a specialised B-cell lineage, (*) evolutionary events
Fig 2The possible picture of thrombocyte evolution in non mammalian vertebrates towards formation of platelets in mammalian vertebrates
Cytochemical and immunocytochemical properties of thrombocytes compared to properties of neutrophilic granulocytes (PMNc) in Osteichthyes
| Cytochemical and immunocytochemical substances | Thrombocytes positive (+), negative (−), indeterminate (+/−) | Polymorphonuclear cells positive (+), negative (−), indeterminate (+/−) | References |
|---|---|---|---|
| MPO | (+) and (−) | (+) | 3, 31, 35 |
| Lysozyme | (+) | (+) | 24 |
| ACP | (+) and (−) | (+) and (+/−) | 3, 35 |
| ALP | (−) | (+) and (−) | 3, 35 |
| β-glucuronidase | (−) | (+/−) | 35 |
| ASDE | (+) and (−) | (+) | 31, 35 |
| αNAE (ANAE) | (+) and (−) | (+) | 3, 35 |
| αNBE | (−) | (+) and (−) | 35 |
| SBB | (−) | (+) | 3, 35 |
| PAS | (+) and (+/−) | (+) | 1, 3, 33, 35, 43, 44, 45 |
| MMP2 | (−) | (+) | 3 |
| MMP9 | (+) and (−) | (+) | 3, 5 |
Properties/characteristics of immunological importance, found in thrombocytes of Osteichthyes
| Property/characteristics | Biological function | References |
|---|---|---|
| MHC II (dab1/2, dab3/4) | proteins responsible for antigen presentation to T-lymphocytes | 5, 9, 24 |
| MHC Ia, MHC IIB | 22 | |
| β2m, LMP, TAP1, TAP2 | molecules responsible for antigen processing and presentation | |
| P-selectin (CD62P) | adhesion molecule | 5, 8 |
| IL1β, IL1r1, IL6a, IL6b, IFNγ2, | pro-inflammatory mediators | 5 |
| p35, p40c (IL12) | 5, 8 | |
| p40a, p40b | 8 | |
| IL1β, iNOS | 5, 24 | |
| TNFα | 5, 22 | |
| IL10, SOCS3_1&2, SOCS3_3&4 | anti-inflammatory mediators | 5 |
| CXCL8_L2, CXCA_L1 | chemokines (CXC), chemotactic cytokines, a group of proteins that stimulate the motion of leukocytes and control their migration from blood to tissues | |
| CXCR1, CXCR2 | chemokine receptor (CXCR) activates the cell response after addition of a suitable chemokine. | |
| CXCR7, CXCR4 | 22 | |
| TLR1, TLR2, TLR5, TLR7, TLR8a, TLR8b, TLR9, TLR20 | PRRs (pattern recognition receptors) which allow for recognition of PAMP microbial antigen patterns and for initiation of non-specific and specific responses. | 5 |
| TLR4 | 30 | |
| LMO2 | a highly conserved protein playing a key role in the haematopoietic process | 14 |
| GATA1 | a transcription factor, crucial for development of specific blood cell types from their precursor cells, necessary for the maturation of, | |
| c-Mpl | a receptor for thrombopoietin, a megakaryocyte receptor of thrombopoietin in mammals | |
| CD11/CD18 (isotype CD11-1/CD18-2) | an analogue of complement receptor 3 (CR3) in mammals, giving the cell an ability to recognise complement-opsonised antigens | 24 |
| CD41 | membrane proteins (a component of integrin αIIb/β3, CD41/CD61), specific thrombocyte markers in different fish species, markers used to identify megakaryocytic precursors, platelets and megakaryocytes in mammals | 14, 17, 24, 29, 42 |
| CD61 | 29 | |
| CD42a | active molecule, known as GPIX, is expressed on megakaryocytes and platelets in the process of platelet aggregation in mammals | 22 |
| TF | tissue factor, a transmembrane protein and cell receptor of plasmatic factor VII, is involved in the immune response regulation | 26 |